Investigation of the Safety and Efficacy of JTT-751 in a Long-term Study in Hemodialysis Patients (2)
Phase 3
- Conditions
- Chronic Kidney Disease
- Registration Number
- JPRN-jRCT2080221398
- Lead Sponsor
- JAPAN TABACCO INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients undergoing hemodialysis 3 times weekly
Exclusion Criteria
Patients with gastrointestinal diseases, such as peptic ulcer
Patients with advanced cardiac disease, or with hepatic dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum P levels
- Secondary Outcome Measures
Name Time Method